Erlotinib-induced skin manifestations

J Dermatol. 2009 Dec;36(12):658-9. doi: 10.1111/j.1346-8138.2009.00727.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Aged
  • Antineoplastic Agents / adverse effects
  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Drug Eruptions / diagnosis
  • Drug Eruptions / drug therapy
  • Drug Eruptions / etiology*
  • ErbB Receptors / antagonists & inhibitors
  • Erlotinib Hydrochloride
  • Female
  • Humans
  • Lung Neoplasms / drug therapy
  • Male
  • Middle Aged
  • Quinazolines / adverse effects*

Substances

  • Adrenal Cortex Hormones
  • Antineoplastic Agents
  • Quinazolines
  • Erlotinib Hydrochloride
  • ErbB Receptors